In this Issue
The future of glaucoma surgery
By Steven D. Vold, MD
By Darrell WuDunn, MD, PhD, and Joshua W. Evans, MD
New technology may reduce reliance on expensive machinery.
By Sahil Thakur, MBBS, and Parul Ichhpujani, MS
The latest results of clinical trials and research studies presented at the 27th Annual Meeting of the American Glaucoma Society, held March 2 to 5, 2017, in Coronado, California.
By Ambika Hoguet, MD, and Lucy Q. Shen, MD
RESIDENTS AND FELLOWS
By Kunjal K. Modi, MD
COVER FOCUS: Blazing a Trail
The future of glaucoma surgery.
By Steven D. Vold, MD, chief medical editor
With Leon W. Herndon, MD; Oluwatosin U. Smith, MD; Mahmoud A. Khaimi, MD; Sameh Mosaed, MD; Michael D. Greenwood, MD; Steven R. Sarkisian Jr, MD; Michael Berlin, MD, MS; Vigan Roka, MD; Michael Riggs; and Ulrich Giers, MD; Steven D. Vold, MD; Marc Töteberg-Harms, MD, FEBO; Erik L. Mertens, MD, FEBOphth, and Howard Barnebey, MD
The FDA launched a collaborative effort with academic centers to develop a patientreported outcome measure and a patient preference study specifically for individuals with mild to moderate glaucoma.
By Michelle E. Tarver, MD, PhD, and Malvina B. Eydelman, MD
What’s the subspecialist’s role?
By Ronald L. Fellman, MD
Can microinvasive glaucoma procedures mitigate complications in children?
By Anna Do, MD, and Joseph F. Panarelli, MD
A literature search reveals interesting findings from 2016.
By Tony Realini, MD, MPH
Endocyclophotocoagulation for glaucoma management.
By Chungkwon Yoo, MD, PhD, and Shan C. Lin, MD
Using this treatment option earlier in the disease course and in sighted eyes.
By James Fox, MD
A blueprint for treatment.
By Edward S. Yung, MD, and Marlene R. Moster, MD
By Robert Watson
OCT angiography, PERG, and corneal hysteresis.